Patient characteristics at baseline. A 48 week placebo controlled trial comparing cyclosporin A (CsA) monotherapy with CsA and methotrexate (MTX) combination therapy in patients with RA with poor prognosis
| Characteristic | CsA plus MTX (n=60) | CsA (n=60) |
|---|---|---|
| *Mean (standard deviation); †Number of patients (percentage). | ||
| Age (years) | 52.5 (10.6)* | 51.2 (11.6)* |
| Disease duration (months) | 2.9 (3.5)* | 2.7 (5.7)* |
| Women | 37 (62)† | 42 (70)† |
| Erosive at start of study | 32 (53)† | 27 (45)† |
| Rheumatoid factor positive at start | 56 (93)† | 58 (97)† |
| DMARD used before study (patients) | 11 (18)† | 6 (10)† |